Silver Book Fact

After 9 years of tight blood pressure control, patients with type 2 diabetes had a 34% reduction in retinopathy progression and a 47% reduction in risk of visual acuity deterioration by three lines, when they had a 10/5 mmHg reduction in blood pressure.

Turner R, Holman R, Stratton I, Cull C, et al. Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes. BMJ. 1998; 317(7160): 703-13. http://www.bmj.com/cgi/content/abstract/317/7160/703

Reference

Title
Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes
Publication
BMJ
Publication Date
1998
Authors
Turner R, Holman R, Stratton I, Cull C, et al
Volume & Issue
Volume 317, Issue 7160
Pages
703-13
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The ACCORD Eye Study found that combination lipid therapy with a fibrate and statin (compared with statin treatment alone) reduced progression of diabetic retinopathy in type 2 diabetics by around…  
  • Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.  
  • Eye Exams: Trends, 1996-2006 (in relation to screening for diabetic retinopathy)  
  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.